Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Daniel Bowles

Concepts (346)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antineoplastic Agents
31
2026
2218
3.320
Why?
Head and Neck Neoplasms
16
2023
563
2.810
Why?
Salivary Gland Neoplasms
8
2023
39
2.780
Why?
Protein Kinase Inhibitors
15
2026
982
2.190
Why?
Carcinoma, Squamous Cell
14
2019
627
2.190
Why?
Pyridines
14
2026
606
2.100
Why?
Thyroid Neoplasms
9
2024
380
1.780
Why?
Carcinoma, Non-Small-Cell Lung
9
2026
1194
1.680
Why?
Molecular Targeted Therapy
7
2021
446
1.610
Why?
Neoplasm Recurrence, Local
7
2023
1156
1.510
Why?
Protein-Tyrosine Kinases
4
2021
429
1.410
Why?
Antineoplastic Combined Chemotherapy Protocols
14
2024
1996
1.390
Why?
Neoplasms
20
2024
2944
1.370
Why?
Lung Neoplasms
11
2026
2674
1.360
Why?
Anilides
6
2024
82
1.320
Why?
Gonanes
7
2016
23
1.300
Why?
Proto-Oncogene Proteins
6
2021
615
1.280
Why?
Thyroid Carcinoma, Anaplastic
3
2020
37
1.230
Why?
Cetuximab
7
2018
110
1.220
Why?
Biomarkers, Tumor
8
2020
1334
1.180
Why?
Adenocarcinoma
7
2024
927
1.170
Why?
Phosphatidylinositol 3-Kinases
8
2017
384
0.800
Why?
Pyrazoles
6
2026
516
0.780
Why?
Mutation
13
2024
4082
0.730
Why?
Carcinoma
3
2019
225
0.700
Why?
Phytotherapy
2
2012
74
0.670
Why?
Drugs, Investigational
2
2011
31
0.670
Why?
Neoplasm Staging
15
2019
1486
0.660
Why?
Cisplatin
6
2024
346
0.650
Why?
Neoplasms, Second Primary
1
2021
103
0.610
Why?
Papillomaviridae
4
2019
113
0.600
Why?
Disease-Free Survival
10
2017
777
0.600
Why?
Taxoids
3
2015
115
0.590
Why?
Antineoplastic Agents, Immunological
2
2018
200
0.590
Why?
Quinolines
5
2024
191
0.580
Why?
Hedgehog Proteins
3
2015
194
0.580
Why?
Carcinoma, Renal Cell
3
2017
229
0.580
Why?
Pyrimidines
6
2026
530
0.570
Why?
Humans
90
2026
145625
0.570
Why?
Marijuana Smoking
2
2012
248
0.540
Why?
Tumor Suppressor Proteins
2
2018
314
0.540
Why?
Proto-Oncogene Proteins c-ret
5
2026
41
0.540
Why?
Drug Resistance, Neoplasm
8
2024
889
0.530
Why?
Middle Aged
44
2026
36359
0.510
Why?
Kidney Neoplasms
3
2017
417
0.500
Why?
Carcinoma, Mucoepidermoid
1
2017
17
0.500
Why?
Colorectal Neoplasms
2
2016
870
0.490
Why?
Aged
40
2026
26251
0.490
Why?
Carcinoma, Transitional Cell
4
2017
70
0.490
Why?
Ubiquitin Thiolesterase
1
2017
70
0.490
Why?
Carcinoma, Ductal
1
2016
10
0.480
Why?
Adenoma, Pleomorphic
1
2016
8
0.480
Why?
Gene Rearrangement
2
2018
155
0.480
Why?
Sulfones
2
2014
127
0.480
Why?
Cannabinoids
2
2024
181
0.460
Why?
Glycine
2
2014
184
0.460
Why?
Maximum Tolerated Dose
5
2017
216
0.430
Why?
Melanoma
1
2021
764
0.410
Why?
Drug Interactions
6
2017
403
0.410
Why?
Enzyme Inhibitors
3
2014
820
0.410
Why?
Pyrroles
1
2014
221
0.390
Why?
Iodine Radioisotopes
5
2024
139
0.390
Why?
Gene Fusion
3
2023
30
0.390
Why?
Signal Transduction
8
2018
5234
0.380
Why?
Receptor Protein-Tyrosine Kinases
2
2012
226
0.380
Why?
Phenylurea Compounds
4
2024
122
0.380
Why?
Male
45
2026
73014
0.370
Why?
Genetic Variation
1
2018
992
0.370
Why?
Lymph Nodes
4
2017
511
0.360
Why?
Indazoles
3
2019
86
0.360
Why?
Aged, 80 and over
16
2026
8351
0.360
Why?
Female
46
2026
79080
0.360
Why?
Quinazolines
1
2013
267
0.350
Why?
Class I Phosphatidylinositol 3-Kinases
4
2017
109
0.340
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2012
128
0.340
Why?
Treatment Outcome
15
2024
11744
0.330
Why?
Antibodies, Monoclonal, Humanized
4
2024
992
0.320
Why?
Neoplasm Metastasis
6
2021
693
0.320
Why?
Adult
27
2026
40821
0.300
Why?
Prognosis
9
2021
4331
0.280
Why?
ErbB Receptors
4
2017
636
0.270
Why?
Benzamides
3
2022
226
0.270
Why?
Papillomavirus Infections
3
2022
345
0.260
Why?
Pharmacogenomic Variants
2
2018
35
0.260
Why?
Urologic Neoplasms
2
2017
31
0.250
Why?
Nitriles
2
2022
211
0.250
Why?
Carcinoma, Ductal, Breast
1
2007
91
0.250
Why?
Platinum
2
2024
48
0.240
Why?
Mitoxantrone
1
2006
14
0.240
Why?
Xenograft Model Antitumor Assays
7
2024
928
0.240
Why?
Enterobacter
1
2006
8
0.240
Why?
Tooth Diseases
1
2006
13
0.240
Why?
Esophageal and Gastric Varices
1
2006
34
0.230
Why?
Gene Expression Profiling
5
2018
1790
0.230
Why?
Enterobacteriaceae Infections
1
2006
43
0.230
Why?
Salivary Glands
2
2023
36
0.230
Why?
Oropharyngeal Neoplasms
2
2016
56
0.230
Why?
Acute Kidney Injury
3
2018
861
0.220
Why?
Animals
16
2024
38030
0.220
Why?
Chemoradiotherapy
4
2020
238
0.220
Why?
Serotonin 5-HT3 Receptor Antagonists
1
2024
5
0.220
Why?
Proto-Oncogene Proteins B-raf
2
2024
230
0.210
Why?
Clinical Trials as Topic
3
2018
1062
0.210
Why?
Receptors, Estrogen
1
2007
405
0.210
Why?
Antiemetics
1
2024
51
0.210
Why?
Cannabis
1
2011
519
0.210
Why?
Immunotherapy
2
2023
669
0.200
Why?
Urinary Bladder Neoplasms
2
2017
257
0.200
Why?
Liver Cirrhosis
1
2006
276
0.200
Why?
Registries
2
2016
2382
0.200
Why?
Carcinoma, Adenoid Cystic
1
2023
18
0.200
Why?
Models, Biological
3
2024
1758
0.200
Why?
Combined Modality Therapy
4
2018
1269
0.200
Why?
Gene Expression Regulation, Neoplastic
3
2019
1429
0.200
Why?
Bacteremia
1
2006
218
0.200
Why?
Administration, Oral
3
2014
867
0.190
Why?
Phenylthiohydantoin
1
2022
44
0.180
Why?
Medical Marijuana
1
2024
119
0.180
Why?
Survival Rate
5
2021
2078
0.170
Why?
Radiation Pneumonitis
1
2021
31
0.170
Why?
Drug Evaluation, Preclinical
2
2013
195
0.170
Why?
Chemotherapy, Adjuvant
3
2017
429
0.170
Why?
Survival Analysis
4
2020
1372
0.170
Why?
Carcinoma, Neuroendocrine
1
2021
38
0.160
Why?
Referral and Consultation
1
2007
878
0.160
Why?
Disease Susceptibility
2
2020
339
0.160
Why?
Adrenal Cortex Neoplasms
1
2021
70
0.160
Why?
TOR Serine-Threonine Kinases
2
2016
454
0.160
Why?
Adrenocortical Carcinoma
1
2021
72
0.160
Why?
Gene Expression
2
2015
1461
0.160
Why?
Cystectomy
2
2017
44
0.150
Why?
SEER Program
1
2021
233
0.150
Why?
Receptors, Nerve Growth Factor
1
2019
17
0.150
Why?
Kaplan-Meier Estimate
3
2017
959
0.150
Why?
DNA Mutational Analysis
2
2018
409
0.150
Why?
Leukemia, Myeloid, Acute
1
2006
700
0.150
Why?
Lymph Node Excision
2
2017
173
0.150
Why?
Tracheal Neoplasms
1
2019
11
0.150
Why?
Prostatic Neoplasms
1
2006
972
0.140
Why?
Smad4 Protein
1
2019
33
0.140
Why?
United States
8
2021
16041
0.140
Why?
Positron Emission Tomography Computed Tomography
1
2020
122
0.140
Why?
Alphapapillomavirus
2
2016
35
0.140
Why?
Radiosurgery
1
2022
398
0.140
Why?
Benzazepines
1
2018
35
0.140
Why?
Genetic Heterogeneity
1
2019
66
0.140
Why?
Risk
1
2021
917
0.140
Why?
Disease Management
2
2020
649
0.140
Why?
Genomics
3
2021
851
0.140
Why?
Chromosome Aberrations
1
2019
167
0.130
Why?
DNA Mismatch Repair
1
2018
54
0.130
Why?
Tissue Fixation
1
2017
35
0.130
Why?
Paraffin Embedding
1
2017
33
0.130
Why?
Oncogenes
1
2018
113
0.130
Why?
Smokers
1
2018
139
0.130
Why?
Erlotinib Hydrochloride
1
2017
71
0.130
Why?
Formaldehyde
1
2017
65
0.130
Why?
Nasopharyngeal Neoplasms
1
2017
21
0.130
Why?
Gene Deletion
1
2019
384
0.130
Why?
Radiotherapy, Intensity-Modulated
1
2018
143
0.130
Why?
DNA, Neoplasm
1
2017
160
0.130
Why?
Neoplasm Grading
1
2018
313
0.120
Why?
Health Services Needs and Demand
1
2019
283
0.120
Why?
Gene Frequency
1
2018
495
0.120
Why?
Chemoradiotherapy, Adjuvant
1
2016
44
0.120
Why?
Salivary Ducts
1
2016
2
0.120
Why?
Induction Chemotherapy
1
2017
87
0.120
Why?
Laryngeal Neoplasms
1
2016
36
0.120
Why?
Palliative Care
2
2018
1032
0.120
Why?
Muscle, Smooth
1
2017
152
0.120
Why?
Carboplatin
1
2016
168
0.120
Why?
Nomograms
1
2016
59
0.120
Why?
Dose-Response Relationship, Drug
3
2017
2018
0.120
Why?
Hospice and Palliative Care Nursing
1
2018
115
0.120
Why?
Database Management Systems
1
2016
50
0.120
Why?
Prospective Studies
7
2024
8087
0.110
Why?
Patient Navigation
1
2018
126
0.110
Why?
Population Surveillance
1
2019
477
0.110
Why?
Disease Progression
4
2018
2857
0.110
Why?
Computational Biology
2
2018
675
0.110
Why?
Young Adult
5
2021
14240
0.110
Why?
Angiopoietin-1
1
2015
12
0.110
Why?
Angiopoietin-2
1
2015
15
0.110
Why?
Radiotherapy
1
2016
209
0.110
Why?
Incidence
2
2019
2910
0.110
Why?
Zinc Finger Protein GLI1
1
2014
23
0.110
Why?
Bone Neoplasms
1
2017
271
0.110
Why?
Genetic Testing
1
2018
491
0.110
Why?
Retrospective Studies
8
2021
17291
0.110
Why?
Retreatment
1
2014
79
0.110
Why?
Hospice Care
1
2018
230
0.100
Why?
Response Evaluation Criteria in Solid Tumors
1
2014
21
0.100
Why?
Breast Neoplasms
1
2007
2411
0.100
Why?
Piperazines
2
2018
367
0.100
Why?
Neoplasms, Unknown Primary
1
2014
20
0.100
Why?
Neoplastic Stem Cells
1
2018
402
0.100
Why?
Proto-Oncogene Proteins c-akt
1
2016
438
0.100
Why?
Paclitaxel
1
2015
258
0.100
Why?
High-Throughput Nucleotide Sequencing
1
2017
538
0.100
Why?
Patient Satisfaction
1
2018
698
0.100
Why?
Veratrum Alkaloids
1
2013
20
0.100
Why?
Promoter Regions, Genetic
1
2018
1236
0.100
Why?
ras Proteins
1
2014
148
0.100
Why?
Sulfonamides
1
2017
592
0.100
Why?
Proportional Hazards Models
4
2017
1318
0.100
Why?
Proto-Oncogene Proteins p21(ras)
1
2014
250
0.090
Why?
PTEN Phosphohydrolase
1
2014
166
0.090
Why?
Pilot Projects
2
2015
1878
0.090
Why?
Cell Cycle Proteins
2
2014
629
0.090
Why?
Imatinib Mesylate
1
2012
77
0.090
Why?
Dasatinib
1
2012
58
0.090
Why?
Recombinant Fusion Proteins
1
2015
662
0.090
Why?
Risk Assessment
2
2019
3678
0.090
Why?
Smoking
1
2019
1478
0.090
Why?
Thiazoles
1
2012
139
0.090
Why?
Aniline Compounds
1
2012
120
0.090
Why?
Biomarkers
3
2018
4329
0.090
Why?
Proto-Oncogene Proteins c-met
1
2012
76
0.080
Why?
Hematopoietic Stem Cells
1
2015
432
0.080
Why?
Evidence-Based Medicine
2
2012
727
0.080
Why?
Biological Availability
1
2011
146
0.080
Why?
Phosphatidylinositol 3-Kinase
1
2011
24
0.080
Why?
Imidazoles
1
2012
244
0.080
Why?
Mice
7
2024
18266
0.080
Why?
Vascular Endothelial Growth Factor A
2
2024
543
0.080
Why?
Adolescent
5
2022
22451
0.080
Why?
Propensity Score
3
2017
370
0.080
Why?
Tumor Microenvironment
1
2015
745
0.080
Why?
Cell Line, Tumor
4
2024
3538
0.080
Why?
Phenotype
1
2018
3186
0.080
Why?
Algorithms
1
2018
1843
0.080
Why?
Genetic Predisposition to Disease
1
2018
2455
0.070
Why?
Kidney
1
2017
1491
0.070
Why?
Multivariate Analysis
3
2017
1531
0.070
Why?
Receptors, Vascular Endothelial Growth Factor
2
2024
109
0.070
Why?
Adaptation, Psychological
1
2014
718
0.070
Why?
Brain Neoplasms
1
2018
1324
0.070
Why?
Axilla
1
2007
51
0.060
Why?
Clinical Trials, Phase I as Topic
2
2019
49
0.060
Why?
Cohort Studies
4
2022
6045
0.060
Why?
Sentinel Lymph Node Biopsy
1
2007
117
0.060
Why?
Neoadjuvant Therapy
2
2022
474
0.060
Why?
RNA, Messenger
1
2014
2783
0.060
Why?
Transcription Factors
1
2014
1728
0.060
Why?
Ligation
1
2006
88
0.060
Why?
Pain
1
2011
787
0.060
Why?
Mastectomy
1
2007
188
0.060
Why?
Receptors, Progesterone
1
2007
241
0.060
Why?
Stress, Psychological
1
2014
1169
0.060
Why?
Creatinine
2
2018
511
0.060
Why?
Fatal Outcome
1
2006
302
0.060
Why?
Lymphatic Metastasis
2
2017
335
0.060
Why?
Neoplasm Invasiveness
2
2017
503
0.060
Why?
Caregivers
1
2014
1079
0.060
Why?
Granisetron
1
2024
6
0.050
Why?
Quinuclidines
1
2024
11
0.050
Why?
Ondansetron
1
2024
19
0.050
Why?
Skin Neoplasms
1
2012
805
0.050
Why?
Double-Blind Method
2
2021
2064
0.050
Why?
Isoquinolines
1
2024
44
0.050
Why?
Gastrointestinal Hemorrhage
1
2006
133
0.050
Why?
Risk Factors
1
2019
10840
0.050
Why?
Neoplasm Proteins
1
2007
443
0.050
Why?
Oncogene Proteins, Fusion
1
2026
212
0.050
Why?
Glomerular Filtration Rate
2
2018
743
0.050
Why?
Demography
2
2015
274
0.050
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2023
86
0.050
Why?
Benzimidazoles
1
2024
189
0.050
Why?
Recurrence
2
2018
1125
0.050
Why?
Databases, Factual
2
2019
1481
0.040
Why?
Four-Dimensional Computed Tomography
1
2021
38
0.040
Why?
Androgen Antagonists
1
2022
91
0.040
Why?
Immunohistochemistry
2
2018
1709
0.040
Why?
Pulmonary Ventilation
1
2021
80
0.040
Why?
Receptors, Androgen
1
2022
149
0.040
Why?
Quality of Life
1
2013
3187
0.040
Why?
Radiotherapy Planning, Computer-Assisted
1
2021
150
0.040
Why?
Receptor, trkC
1
2019
10
0.040
Why?
Receptor, trkA
1
2019
17
0.040
Why?
Clinical Trials, Phase II as Topic
1
2019
74
0.040
Why?
Receptor, trkB
1
2019
39
0.040
Why?
Trastuzumab
1
2019
119
0.040
Why?
Extracellular Signal-Regulated MAP Kinases
1
2020
173
0.040
Why?
Radiotherapy, Image-Guided
1
2018
40
0.030
Why?
Phthalazines
1
2018
63
0.030
Why?
In Situ Hybridization, Fluorescence
1
2019
333
0.030
Why?
Organic Cation Transporter 2
1
2017
8
0.030
Why?
Glutathione S-Transferase pi
1
2017
10
0.030
Why?
Retroperitoneal Space
1
2017
19
0.030
Why?
Organic Cation Transport Proteins
1
2017
25
0.030
Why?
Urinary Diversion
1
2017
14
0.030
Why?
Tumor Cells, Cultured
1
2019
878
0.030
Why?
National Cancer Institute (U.S.)
1
2017
55
0.030
Why?
Social Work
1
2018
84
0.030
Why?
Membrane Glycoproteins
1
2019
495
0.030
Why?
Margins of Excision
1
2017
54
0.030
Why?
Immunophenotyping
1
2018
324
0.030
Why?
Hospitals, Veterans
1
2018
256
0.030
Why?
Laryngectomy
1
2016
17
0.030
Why?
Kidney Function Tests
1
2017
154
0.030
Why?
Oncologists
1
2017
47
0.030
Why?
Cation Transport Proteins
1
2017
120
0.030
Why?
Viral Core Proteins
1
2016
21
0.030
Why?
Carcinogenesis
1
2018
226
0.030
Why?
Pelvis
1
2017
129
0.030
Why?
Regression Analysis
1
2018
994
0.030
Why?
Heart
1
2020
624
0.030
Why?
Radiotherapy, Adjuvant
1
2016
222
0.030
Why?
Disease Models, Animal
2
2018
4565
0.030
Why?
Internationality
1
2016
156
0.030
Why?
Random Allocation
1
2016
365
0.030
Why?
Antibodies, Monoclonal
1
2022
1511
0.030
Why?
Antibodies, Neoplasm
1
2015
34
0.030
Why?
Anti-Bacterial Agents
1
2006
1935
0.030
Why?
Biopsy, Large-Core Needle
1
2014
15
0.030
Why?
Myocardium
1
2020
948
0.030
Why?
Analysis of Variance
1
2017
1293
0.030
Why?
Robotic Surgical Procedures
1
2017
204
0.030
Why?
Bone Marrow
1
2015
308
0.020
Why?
Receptor, Notch2
1
2013
15
0.020
Why?
Receptor Cross-Talk
1
2013
24
0.020
Why?
Receptor, Notch1
1
2013
62
0.020
Why?
Psychiatric Status Rating Scales
1
2014
512
0.020
Why?
Metabolic Clearance Rate
1
2012
115
0.020
Why?
Pandemics
1
2021
1700
0.020
Why?
Gene Silencing
1
2013
200
0.020
Why?
Nausea
1
2012
111
0.020
Why?
Logistic Models
1
2017
2112
0.020
Why?
Vomiting
1
2012
131
0.020
Why?
Needs Assessment
1
2014
403
0.020
Why?
Area Under Curve
1
2012
333
0.020
Why?
Transcriptome
1
2018
1066
0.020
Why?
Mice, Nude
1
2013
665
0.020
Why?
Diarrhea
1
2012
190
0.020
Why?
Blotting, Western
1
2013
1176
0.020
Why?
Drug Administration Schedule
1
2012
782
0.020
Why?
Cell Proliferation
1
2017
2497
0.020
Why?
Fatigue
1
2012
362
0.020
Why?
Time Factors
1
2019
7079
0.020
Why?
Age Factors
1
2016
3321
0.020
Why?
Lung
1
2021
4119
0.020
Why?
Colorado
1
2018
4588
0.020
Why?
Cytokines
1
2015
2079
0.020
Why?
Follow-Up Studies
1
2016
5397
0.020
Why?
Surveys and Questionnaires
1
2018
6050
0.010
Why?
Cross-Sectional Studies
1
2014
5875
0.010
Why?
Bowles's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)